Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2011 1
2012 2
2015 1
2016 2
2017 3
2018 2
2019 3
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
The Evolving Treatment Landscape of Merkel Cell Carcinoma.
Singh N, McClure EM, Akaike T, Park SY, Huynh ET, Goff PH, Nghiem P. Singh N, et al. Curr Treat Options Oncol. 2023 Sep;24(9):1231-1258. doi: 10.1007/s11864-023-01118-8. Epub 2023 Jul 5. Curr Treat Options Oncol. 2023. PMID: 37403007 Review.
Merkel cell carcinoma (MCC) has a high risk of recurrence and requires unique treatment relative to other skin cancers. ...Cytotoxic chemotherapy is sometimes used for debulking disease or in patients who cannot tolerate ICI. ICI-refractory disease is the major prob …
Merkel cell carcinoma (MCC) has a high risk of recurrence and requires unique treatment relative to other skin cancers. ...Cytotoxic …
Treatment of Aggressive Thyroid Cancer.
Huang J, Harris EJ, Lorch JH. Huang J, et al. Surg Pathol Clin. 2019 Dec;12(4):943-950. doi: 10.1016/j.path.2019.08.004. Surg Pathol Clin. 2019. PMID: 31672300 Review.
Although thyroid cancer generally has a good prognosis, there is a subset of patients for whom standard care (ie, treatment limited to surgery or surgery plus radioactive iodine) is either not appropriate because of the aggressive nature of their disease or not sufficient …
Although thyroid cancer generally has a good prognosis, there is a subset of patients for whom standard care (ie, treatment limited t …
Merkel cell carcinoma: a review of clinical management with focus on Asian patients.
Nakano E, Ogata D, Namikawa K, Yamazaki N. Nakano E, et al. Jpn J Clin Oncol. 2023 Jul 31;53(8):673-679. doi: 10.1093/jjco/hyad059. Jpn J Clin Oncol. 2023. PMID: 37288476 Review.
Merkel cell carcinoma is a highly aggressive skin cancer characterized by neuroendocrine differentiation. ...Patients with distant Merkel cell carcinoma are administered immune checkpoint inhibitors as the first-line therapy; however, there is no estab …
Merkel cell carcinoma is a highly aggressive skin cancer characterized by neuroendocrine differentiation. ...Patients with dis …
Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.
Femia D, Prinzi N, Anichini A, Mortarini R, Nichetti F, Corti F, Torchio M, Peverelli G, Pagani F, Maurichi A, Mattavelli I, Milione M, Bedini N, Corti A, Di Bartolomeo M, de Braud F, Pusceddu S. Femia D, et al. Target Oncol. 2018 Oct;13(5):567-582. doi: 10.1007/s11523-018-0585-y. Target Oncol. 2018. PMID: 30073632 Review.
Advanced Merkel cell carcinoma (MCC) is a very aggressive, rare neuroendocrine tumor of the skin with a high frequency of locoregional recurrence and metastasis, and a high mortality rate. ...More recently, immunotherapy agents such as avelumab, pembrolizumab, and n …
Advanced Merkel cell carcinoma (MCC) is a very aggressive, rare neuroendocrine tumor of the skin with a high frequency of loco …
Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
Rusinek D, Chmielik E, Krajewska J, Jarzab M, Oczko-Wojciechowska M, Czarniecka A, Jarzab B. Rusinek D, et al. Int J Mol Sci. 2017 Aug 22;18(8):1817. doi: 10.3390/ijms18081817. Int J Mol Sci. 2017. PMID: 28829399 Free PMC article. Review.
We discussed the controversies regarding the extent of thyroid surgery and adjuvant radioiodine therapy, as well as new treatment modalities for radioiodine-refractory differentiated thyroid cancer (RR-DTC). Considering medullary thyroid cancer (MTC), we analyzed a …
We discussed the controversies regarding the extent of thyroid surgery and adjuvant radioiodine therapy, as well as new treatment mod …
Avelumab for the treatment of metastatic Merkel cell carcinoma.
Cordes LM, Gulley JL. Cordes LM, et al. Drugs Today (Barc). 2017 Jul;53(7):377-383. doi: 10.1358/dot.2017.53.7.2654888. Drugs Today (Barc). 2017. PMID: 28837181 Free PMC article. Review.
Avelumab is a promising new therapeutic agent for patients with metastatic Merkel cell carcinoma, a rare and aggressive type of neuroendocrine tumor of the skin. Until the recent approval of avelumab (Bavencio), no therapies were approved by the U.S. F …
Avelumab is a promising new therapeutic agent for patients with metastatic Merkel cell carcinoma, a rare and aggressive type o …
Update on thyroid cancer treatment.
Regalbuto C, Frasca F, Pellegriti G, Malandrino P, Marturano I, Di Carlo I, Pezzino V. Regalbuto C, et al. Future Oncol. 2012 Oct;8(10):1331-48. doi: 10.2217/fon.12.123. Future Oncol. 2012. PMID: 23130931 Review.
However, poorly differentiated and anaplastic thyroid carcinomas represent a challenge to physicians on the basis of the current cancer treatment modalities. These cancer subtypes are often lethal and refractory to radioiodine therapy as well as most of the common c …
However, poorly differentiated and anaplastic thyroid carcinomas represent a challenge to physicians on the basis of the current cancer trea …
Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
Ciarallo A, Marcus C, Taghipour M, Subramaniam RM. Ciarallo A, et al. PET Clin. 2015 Apr;10(2):265-78. doi: 10.1016/j.cpet.2014.12.009. Epub 2015 Jan 29. PET Clin. 2015. PMID: 25829091 Review.
"Fluorodeoxyglucose (FDG) PET/computed tomography (CT) is used most frequently in the surveillance of iodine-refractory differentiated thyroid cancer with increased thyroglobulin level after therapy. ...
"Fluorodeoxyglucose (FDG) PET/computed tomography (CT) is used most frequently in the surveillance of iodine-refractory differentiate …
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.
Msaouel P, Hong AL, Mullen EA, Atkins MB, Walker CL, Lee CH, Carden MA, Genovese G, Linehan WM, Rao P, Merino MJ, Grodman H, Dome JS, Fernandez CV, Geller JI, Apolo AB, Daw NC, Hodges HC, Moxey-Mims M, Wei D, Bottaro DP, Staehler M, Karam JA, Rathmell WK, Tannir NM. Msaouel P, et al. Clin Genitourin Cancer. 2019 Feb;17(1):1-6. doi: 10.1016/j.clgc.2018.09.005. Epub 2018 Sep 12. Clin Genitourin Cancer. 2019. PMID: 30287223 Free PMC article.
Renal medullary carcinoma (RMC) is one of the most aggressive renal cell carcinomas. It predominantly afflicts young adults and adolescents with sickle cell trait and other sickle hemoglobinopathies, and is refractory to targeted and antiangiogenic therapies …
Renal medullary carcinoma (RMC) is one of the most aggressive renal cell carcinomas. It predominantly afflicts young adults and adole …
Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Coldwell D, Sangro B, Salem R, Wasan H, Kennedy A. Coldwell D, et al. Am J Clin Oncol. 2012 Apr;35(2):167-77. doi: 10.1097/COC.0b013e3181f47923. Am J Clin Oncol. 2012. PMID: 21127414 Review.
Radioembolization is a proven treatment to slow disease progression and improve survival in patients with colorectal cancer liver metastases and hepatocellular carcinoma. Accumulating evidence supports its use in metastases from neuroendocrine tumors and breast canc …
Radioembolization is a proven treatment to slow disease progression and improve survival in patients with colorectal cancer liver metastases …
18 results